dc.contributorUniversidade Federal de Juiz de Fora (UFJF)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T13:24:16Z
dc.date.available2014-05-20T13:24:16Z
dc.date.created2014-05-20T13:24:16Z
dc.date.issued2011-06-01
dc.identifierBiomedicine & Pharmacotherapy. Paris: Elsevier France-editions Scientifiques Medicales Elsevier, v. 65, n. 3, p. 204-209, 2011.
dc.identifier0753-3322
dc.identifierhttp://hdl.handle.net/11449/7484
dc.identifier10.1016/j.biopha.2011.01.003
dc.identifierWOS:000296960200011
dc.identifier2114570774349859
dc.description.abstractA series of 4-amino-7-chloroquinoline derivatives were synthesized by the reaction of 4,7-dichloroquinoline with the corresponding diamine and then with propargyl bromide. In addition, platinum(II) complexes were obtained by reacting some of the organic derivatives with K(2)PtCl(4). Several of the synthesized compounds displayed antituberculosis activities. Compound 3 was 47.5 times more active than amphotericin B against Leishmania chagasi (IC(50) = 0.04 mu g/mL). Compounds 5, 6, 7, 9, 10, 11 and 13 presented promising results against Mycobacterium tuberculosis, with MIC values ranging from 12.5 to 15.6 mu g/mL, comparable to the "first and second line'' drugs used to treat tuberculosis. (C) 2011 Elsevier Masson SAS. All rights reserved.
dc.languageeng
dc.publisherElsevier France-editions Scientifiques Medicales Elsevier
dc.relationBiomedicine & Pharmacotherapy
dc.relation3.457
dc.relation0,951
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subject4-aminoquinoline analogues
dc.subjectPlatinum(II) complexes
dc.subjectAntileishmanial
dc.subjectAntitubercular
dc.subjectLeishmania
dc.subjectMycobacterium tuberculosis
dc.titleSynthesis of 4-aminoquinoline analogues and their platinum(II) complexes as new antileishmanial and antitubercular agents
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución